<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04844255</url>
  </required_header>
  <id_info>
    <org_study_id>PACTR202102852000433</org_study_id>
    <nct_id>NCT04844255</nct_id>
  </id_info>
  <brief_title>Acute Salt Sensitivity of Blood Pressure</brief_title>
  <acronym>AcuteSS</acronym>
  <official_title>HIV Integrated Personalized Care Approach to the Prevention, Diagnosis, and Control of Salt-sensitive Hypertension: The HIPO CAP DICTSH STUDY</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mulungushi University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Zambia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mulungushi University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Dietary salt raises blood pressure in certain individuals immediately after ingestion (acute&#xD;
      salt sensitivity; ASS) while not affecting others. It is hypothesized that ASS is a risk&#xD;
      factor for hypertension. However, no thresholds or diagnostic guideline is available for ASS.&#xD;
      This study is the first aim in the main study (HIPO CAP DITSH Study) aimed at determining the&#xD;
      threshold or blood pressure cut-offs for ASS upon ingesting dietary salt.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 1, 2020</start_date>
  <completion_date type="Actual">February 28, 2021</completion_date>
  <primary_completion_date type="Actual">February 28, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Time series design</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Acute salt sensitivity</measure>
    <time_frame>160 minutes</time_frame>
    <description>Mean arterial pressure change of 10 mmHg</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diastolic blood pressure change</measure>
    <time_frame>160 minutes</time_frame>
    <description>Diastolic blood pressure change of equal to or more than 10 mmHg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systolic blood pressure change</measure>
    <time_frame>160 minutes</time_frame>
    <description>Systolic blood pressure change of equal to or more than 20 mmHg</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">132</enrollment>
  <condition>Blood Pressure</condition>
  <arm_group>
    <arm_group_label>Pre and post intervention group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Same individuals are examined before and after taking 2 tablets of salt</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>dietary salt</intervention_name>
    <description>2 grams of dietary salt</description>
    <arm_group_label>Pre and post intervention group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adults aged 18 years and above. Normotensive. If Hypertensive (should be off&#xD;
             antihypertensive medication at least 2 weeks prior to the study)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  diabetes patients, ill participants&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sepiso K Masenga, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mulungushi University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Livingstone Central Hospital</name>
      <address>
        <city>Livingstone</city>
        <state>Southern</state>
        <zip>10101</zip>
        <country>Zambia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Zambia</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 9, 2021</study_first_submitted>
  <study_first_submitted_qc>April 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 14, 2021</study_first_posted>
  <last_update_submitted>April 13, 2021</last_update_submitted>
  <last_update_submitted_qc>April 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mulungushi University</investigator_affiliation>
    <investigator_full_name>Sepiso K. Masenga</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <keyword>salt sensitivity</keyword>
  <keyword>salt</keyword>
  <keyword>acute salt sensitivity</keyword>
  <keyword>Blood pressure</keyword>
  <keyword>Mean arterial pressure</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Individual participant data will be made available after publication upon request.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>After publishing results</ipd_time_frame>
    <ipd_access_criteria>email and published article (open access)</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

